Tyra Biosciences, Inc. (TYRA): Price and Financial Metrics
TYRA Price/Volume Stats
Current price | $12.67 | 52-week high | $29.60 |
Prev. close | $13.17 | 52-week low | $12.60 |
Day low | $12.60 | Volume | 509,500 |
Day high | $13.44 | Avg. volume | 273,636 |
50-day MA | $15.12 | Dividend yield | N/A |
200-day MA | $18.56 | Market Cap | 641.14M |
TYRA Stock Price Chart Interactive Chart >
Tyra Biosciences, Inc. (TYRA) Company Bio
Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The company is also developing programs targeting FGFR2-related cancers, FGFR3-related achondroplasia, REarranged during transfection kinase, and FGFR4-related cancers. Tyra Biosciences, Inc. was incorporated in 2018 and is headquartered in Carlsbad, California.
TYRA Price Returns
1-mo | N/A |
3-mo | -21.35% |
6-mo | -37.34% |
1-year | -31.22% |
3-year | -0.78% |
5-year | N/A |
YTD | -8.85% |
2024 | 0.36% |
2023 | 82.24% |
2022 | -45.98% |
2021 | N/A |
2020 | N/A |
Loading social stream, please wait...